TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2016

A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09.

Ki Hyeong Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.